Harmony Biosciences Holdings, Inc. Insider Transactions
Harmony Biosciences Holdings, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Valor IV Pharma Holdings, LLC
10 percent owner |
Sell | 600,000 @ $30.30 | $18.18 M | 6,618,033 | 11/05/2024 | 11/05/2024 | |
|
Marshman Fund Trust II
10 percent owner |
Sell | 600,000 @ $30.30 | $18.18 M | 6,051,120 | 11/05/2024 | 11/05/2024 | |
|
Valor IV Pharma Holdings, LLC
10 percent owner |
Sell | 4,000,000 @ $30.30 | $121.21 M | 7,218,033 | 11/01/2024 | 11/05/2024 | |
|
Marshman Fund Trust II
10 percent owner |
Sell | 4,000,000 @ $30.30 | $121.21 M | 6,651,120 | 11/01/2024 | 11/05/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 21,496 @ $40.47 | $870,018 | 0 | 10/29/2024 | 10/31/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 400 @ $40.19 | $16,077 | 0 | 10/01/2024 | 10/02/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 35,846 @ $40.03 | $1.43 M | 0 | 09/30/2024 | 10/01/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 200 @ $40.05 | $8,009 | 0 | 09/27/2024 | 09/30/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 11,979 @ $32.00 | $383,328 | 0 | 03/15/2024 | 03/18/2024 | |
|
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER |
Sell | 194 @ $32.00 | $6,208 | 0 | 03/08/2024 | 03/11/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Harmony Biosciences Holdings, Inc. FAQ's
The list of insiders at Harmony Biosciences Holdings, Inc. includes Dierks Jeffrey, Marshman Fund Trust II, Valor IV Pharma Holdings, LLC.
Insiders have sold a total of 9.27 M Harmony Biosciences Holdings, Inc. shares in the last 12 months for a total of 281.50 M sold.
The following insiders have sold Harmony Biosciences Holdings, Inc. shares in the last 12 months: Dierks Jeffrey ($2.71 M), Marshman Fund Trust II ($139.39 M), Valor IV Pharma Holdings, LLC ($139.39 M),